Dicerna Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Watertown MA United States (2007)
Status: Acquired by Novo Nordisk (2021)

Organization Overview

First Clinical Trial
2014
NCT02110563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dicerna Pharmaceuticals | Dicerna Pharmaceuticals, Inc.